Cancer is the leading cause of death in older dogs and cats
CLIFTON, N.J.–(BUSINESS WIRE)–Sandy Mainardi was devastated when Baci, her 13-year-old dog, began
experiencing seizures, slipped into a coma, and was eventually diagnosed
with a brain tumor. The prognosis was bleak.
Now, just 10 months later, the resident of Lincoln Park, New Jersey has
seen her beloved Toy Poodle go through a remarkable turnaround. Thanks
to an emerging new cancer treatment called stereotactic
radiosurgery (SRS), Baci is back to running, jumping and even
winning first-place in his class at the World
Cynosport Rally Limited (WCRL) competition.
November is Pet
Cancer Awareness Month, the perfect time to cheer those currently
battling cancer, celebrate those who have survived, and pay tribute to
those who have passed on. This year, it is also a perfect opportunity to
spread the word about SRS, a treatment delivered with the intent to cure
that is emerging as a leading treatment option in veterinary oncology.
Already widely used in human cancer treatment, SRS is an advanced form
of radiation therapy that offers tremendous benefits. SRS is a
non-invasive, non-surgical treatment that delivers high doses of
radiation with sub-millimeter precision to maximize damage to tumorous
tissue while minimizing collateral damage to nearby healthy tissue. As a
result, SRS requires only 1-3 treatment sessions – an 80-95% reduction
compared to conventional radiation therapy – and significantly reduces
both the severity and duration of side effects.
As Mainardi learned, the conversation surrounding cancer care for pets
is changing for the better – and fast. The groundbreaking new treatment,
provided by PetCure
Oncology at Veterinary Radiosurgery & Imaging Center (VRIC) in
Clifton, NJ, was a life-changing experience for her family.
Oncology is revolutionizing cancer care for pets by partnering with
established veterinary specialty practices and establishing a national
network of centers that specialize in the delivery of advanced radiation
therapy and SRS. Centers in Phoenix,
NJ are now open. Locations in Wisconsin and Illinois are slated to
open in the next few months, with many more centers in various stages of
development across the country.
Pet owners in the northeast may access this advanced technology via
referral to PetCure Oncology at VRIC, 1071 Paulison Avenue, Clifton, New
Jersey. To learn more or obtain a referral, call 973.772.9902 or visit PetCureOncology.com.
JoAnn Stewart, RVT, CVPM